Furthermore, Becker JH et al. considered that CXCR7 inhibition could prevent the emergence of acquired EGFR tyrosine kinase inhibitor (TKI) resistance in EGFR mutant NSCLC with an EMT phenotype [38]. Here, EGFR is linked to non-small cell lung carcinoma.